Leerink Swann Raises Revenue, EPS Estimates for Illumina

Analyst Dan Leonard said growth will be driven by what he expects to be record-breaking sales of Illumina's next-generation sequencing platforms, including its HiSeq, in the first and second quarters of 2011.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.